Cresco Labs (CRLBF) Non-Current Assets (2019 - 2026)

Cresco Labs (CRLBF) posted Non-Current Assets of $952.2 million for Q1 2026, up 1.51% on a QoQ basis from $938.0 million in Q4 2025, and down 9.57% year-over-year from $1.1 billion in Q1 2025.

Cresco Labs (CRLBF) Non-Current Assets (2019 - 2026) Analysis & Trends

Cresco Labs' Non-Current Assets history runs 8 years deep, the most recent figure standing at $952.2 million for Q1 2026.

  • Quarterly Non-Current Assets fell 9.57% year-over-year to $952.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $952.2 million (down 9.57% YoY) and the FY2025 annual result came in at $938.0 million, down 11.6% from the prior year.
  • Non-Current Assets was $952.2 million for Q1 2026 at Cresco Labs, up from $938.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.4 billion in Q3 2022 and bottomed at $938.0 million in Q4 2025.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets surged 35.08% — and 2023, when it slipped 21.78%.
  • Cresco Labs' Non-Current Assets stood at $1.3 billion in 2022, then slipped by 14.1% to $1.1 billion in 2023, then dropped by 1.78% to $1.1 billion in 2024, then decreased by 11.6% to $938.0 million in 2025, then increased by 1.51% to $952.2 million in 2026.
  • Business Quant data shows CRLBF's Non-Current Assets at $952.2 million in Q1 2026, $938.0 million in Q4 2025, and $1.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn 952.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 952.19 Mn
Dec 31, 2025 938.03 Mn
Sep 30, 2025 1.04 Bn
Jun 30, 2025 1.03 Bn
Mar 31, 2025 1.05 Bn
Dec 31, 2024 1.06 Bn
Sep 30, 2024 1.07 Bn
Jun 30, 2024 1.08 Bn
Mar 31, 2024 1.07 Bn
Dec 31, 2023 1.08 Bn
Sep 30, 2023 1.10 Bn
Jun 30, 2023 1.25 Bn
Mar 31, 2023 1.26 Bn
Dec 31, 2022 1.26 Bn
Sep 30, 2022 1.40 Bn
Jun 30, 2022 1.39 Bn
Mar 31, 2022 1.39 Bn
Dec 31, 2021 1.36 Bn
Sep 30, 2021 1.12 Bn
Mar 31, 2021 1.03 Bn